Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 31;27(15):4893.
doi: 10.3390/molecules27154893.

HIF in Gastric Cancer: Regulation and Therapeutic Target

Affiliations
Review

HIF in Gastric Cancer: Regulation and Therapeutic Target

Mengqing Li et al. Molecules. .

Abstract

HIF means hypoxia-inducible factor gene family, and it could regulate various biological processes, including tumor development. In 2021, the FDA approved the new drug Welireg for targeting HIF-2a, and it is mainly used to treat von Hippel-Lindau syndrome, which demonstrated its good prospects in tumor therapy. As the fourth deadliest cancer worldwide, gastric cancer endangers the health of people all across the world. Currently, there are various treatment methods for patients with gastric cancer, but the five-year survival rate of patients with advanced gastric cancer is still not high. Therefore, here we reviewed the regulatory role and target role of HIF in gastric cancer, and provided some references for the treatment of gastric cancer.

Keywords: HIF; gastric cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The mechanism of function of HIF1 under normoxia and hypoxia.
Figure 2
Figure 2
Treatments for advanced gastric cancer.
Figure 3
Figure 3
HIF could regulate the occurrence and development of gastric cancer.
Figure 4
Figure 4
HIF1α/miR-17-5p/PDCD4 axis contributes to the tumor growth of gastric cancer.
Figure 5
Figure 5
HIF1α-Induced LXRα contributes to the metastasis of gastric cancer cells.

Similar articles

Cited by

References

    1. Knutson A.K., Williams A.L., Boisvert W.A., Shohet R.V. HIF in the heart: Development, metabolism, ischemia, and atherosclerosis. J. Clin. Investig. 2021;131:e137557. doi: 10.1172/JCI137557. - DOI - PMC - PubMed
    1. Xue X., Kang J.B., Yang X., Li N., Chang L., Ji J., Meng X.K., Zhang H.Q., Zhong Y., Yu S.P., et al. An efficient strategy for digging protein-protein interactions for rational drug design—A case study with HIF-1α/VHL. Eur. J. Med. Chem. 2022;227:113871. doi: 10.1016/j.ejmech.2021.113871. - DOI - PubMed
    1. He W., Batty-Stuart S., Lee J.E., Ohh M. HIF-1α Hydroxyprolines Modulate Oxygen-Dependent Protein Stability Via Single VHL Interface With Comparable Effect on Ubiquitination Rate. J. Mol. Biol. 2021;433:167244. doi: 10.1016/j.jmb.2021.167244. - DOI - PubMed
    1. Yang Y., Zou P., He L., Shao J., Tang Y., Li J. CBL aggravates Ang II-induced cardiac hypertrophy via the VHL/HIF-1α pathway. Exp. Cell Res. 2021;405:112730. doi: 10.1016/j.yexcr.2021.112730. - DOI - PubMed
    1. Chakraborty A.A. Coalescing lessons from oxygen sensing, tumor metabolism, and epigenetics to target VHL loss in kidney cancer. Pt 2Semin. Cancer Biol. 2020;67:34–42. doi: 10.1016/j.semcancer.2020.03.012. - DOI - PubMed

MeSH terms

Substances